IDEXX Laboratories, Inc. (IDXX)
NASDAQ · Healthcare
IDEXX Laboratories, Inc. EBITDA 2008–2025
IDEXX Laboratories, Inc. annual/quarterly ebitda history and growth rate from 2008 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- IDEXX Laboratories, Inc. ebitda for the quarter ending March 31, 2026 was 400.3 M, a 14.17% increase year-over-year.
- IDEXX Laboratories, Inc. ebitda for the twelve months ending March 31, 2026 was 1.4 B, a 59.67% increase year-over-year.
- IDEXX Laboratories, Inc. annual ebitda for 2025 was 1.5 B, a 19.63% increase from 2024.
- IDEXX Laboratories, Inc. annual ebitda for 2024 was 1.3 B, a 3.81% increase from 2023.
- IDEXX Laboratories, Inc. annual ebitda for 2023 was 1.2 B, a 19.92% increase from 2022.
- IDEXX Laboratories, Inc. annual ebitda for 2022 was 1.0 B.
EBITDA
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
IDEXX Laboratories, Inc. EBITDA — FAQ
IDEXX Laboratories, Inc. (IDXX) ebitda over the last 18 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IDXX's ebitda history?
The chart and table above show IDEXX Laboratories, Inc.'s ebitda by year and by quarter, including the growth rate.